Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

USANA HEALTH SCIENCES INC Director's Dealing 2021

Jul 30, 2021

32704_dirs_2021-07-30_bf60fa6e-9761-4ce7-9597-4c26a389f9ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: USANA HEALTH SCIENCES INC (USNA)
CIK: 0000896264
Period of Report: 2021-07-28

Reporting Person: Pelosi Peggie (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-28 Common Stock M 312 Acquired 1872 Direct
2021-07-28 Common Stock F 136 $99.83 Disposed 1736 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-07-28 Restricted Stock Units $ M 312 Disposed Common Stock (312) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of USNA common stock

F2: Restricted Stock Units vest 25% on July 28, 2021, October 27, 2021, February 9, 2022, and April 27,2022.